J.W. Cole Advisors’s NeuroOne Medical Technologies NMTC Stock Holding History

J.W. Cole Advisors’s Portfolio NMTC Stock Details NMTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6,000	Closed	-$28K	–	1619
2026 Q1	$28K	Hold	6,000	–	–	﹤0.01%	778
2025 Q4	$27.3K	Sell	6,000 -187	-3%	-$852	﹤0.01%	1431
2025 Q3	$33K	Hold	6,187	–	–	﹤0.01%	1527
2025 Q2	$25.2K	Hold	6,187	–	–	﹤0.01%	1449
2025 Q1	$31.6K	Buy	+6,187	New	+$39.3K	﹤0.01%	1237

Other funds holding NMTC

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

PGAM

Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

J.W. Cole Advisors's NMTC Position: Q2 2026 in Review

J.W. Cole Advisors sold out of NeuroOne Medical Technologies (NMTC) in Q2 2026, closing a stake of 6,000 shares — an estimated $28K sold.

J.W. Cole Advisors first reported a position in NMTC in Q1 2025 and held it in 5 quarters. The position peaked at $33K in Q3 2025. 3 funds tracked by Wall St. Rank hold NMTC as of Q2 2026.

J.W. Cole Advisors reported no remaining NeuroOne Medical Technologies position as of Q2 2026 after selling out during the quarter.
J.W. Cole Advisors sold 6,000 NeuroOne Medical Technologies shares in Q2 2026, an estimated $28K.
J.W. Cole Advisors first reported a position in NeuroOne Medical Technologies in Q1 2025 and held it in 5 quarters.
J.W. Cole Advisors's NeuroOne Medical Technologies position peaked at $33K in Q3 2025.
3 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q2 2026.

Based on J.W. Cole Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.